What is VLDL (Very Low-Density Lipoprotein Cholesterol)?

VLDL is a type of cholesterol particle produced by your liver that carries triglycerides through your bloodstream. High VLDL levels increase cardiovascular disease risk and are often linked to metabolic syndrome, diabetes, and obesity.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding VLDL and Its Role in Your Body

Very Low-Density Lipoprotein (VLDL) is one of the five major types of lipoproteins that transport cholesterol and triglycerides through your bloodstream. Think of lipoproteins as specialized delivery vehicles - they're spherical particles made of proteins and lipids that carry fat molecules through your water-based blood, since fat and water don't mix naturally.

Your liver produces VLDL particles primarily to transport triglycerides (a type of fat) from the liver to your body's tissues. While you might be more familiar with LDL (the 'bad' cholesterol) and HDL (the 'good' cholesterol), VLDL plays a crucial intermediary role in your body's lipid metabolism. In fact, VLDL particles eventually transform into LDL particles as they deliver their triglyceride cargo throughout your body.

Understanding your VLDL levels is essential for assessing your cardiovascular health risk. High VLDL cholesterol contributes to the buildup of plaque in your arteries, a condition called atherosclerosis, which can lead to heart disease and stroke. Regular monitoring of your complete lipid profile, including VLDL, provides valuable insights into your metabolic health.

Lipoprotein Comparison: Composition and Function

Lipoprotein TypeCholesterol ContentTriglyceride ContentPrimary Function
VLDLVLDL10-15%50-65%Transport triglycerides from liver
LDLLDL45%10%Deliver cholesterol to cells
HDLHDL20-30%5%Remove excess cholesterol from tissues
IDLIDL35%25%Transitional form between VLDL and LDL

Understanding the composition differences helps explain why VLDL is closely tied to triglyceride levels in blood tests.

How VLDL Differs from Other Cholesterol Types

To understand VLDL's unique role, it helps to compare it with other lipoproteins in your bloodstream. Each type has a different composition and function:

  • VLDL: Contains 10-15% cholesterol and 50-65% triglycerides - primarily transports triglycerides from the liver
  • LDL: Contains 45% cholesterol and only 10% triglycerides - delivers cholesterol to cells throughout the body
  • HDL: Contains 20-30% cholesterol and minimal triglycerides - removes excess cholesterol from tissues and returns it to the liver
  • IDL (Intermediate-Density Lipoprotein): A transitional form between VLDL and LDL
  • Chylomicrons: Transport dietary fats from the intestines to tissues

The key distinction is that VLDL is triglyceride-rich, while LDL is cholesterol-rich. As VLDL particles circulate through your bloodstream, enzymes called lipoprotein lipases break down the triglycerides for use by your muscles and fat cells. This process gradually converts VLDL particles into smaller, denser LDL particles.

This transformation is why VLDL is sometimes called a 'precursor' to LDL cholesterol. Understanding this relationship helps explain why high triglyceride levels (often reflected in high VLDL) frequently accompany high LDL cholesterol levels.

Normal VLDL Levels and How They're Measured

VLDL cholesterol isn't typically measured directly in standard lipid panels. Instead, laboratories usually estimate VLDL levels using a calculation based on your triglyceride levels. The standard formula divides your triglyceride level by 5 (when measured in mg/dL) or by 2.2 (when measured in mmol/L).

Normal VLDL cholesterol levels should be below 30 mg/dL (0.78 mmol/L). However, this calculation method has limitations - it's most accurate when triglyceride levels are below 400 mg/dL. For people with very high triglycerides, more sophisticated testing methods may be necessary for accurate VLDL measurement.

Your VLDL level is best understood as part of your complete lipid profile, which includes:

  • Total cholesterol: Less than 200 mg/dL is desirable
  • LDL cholesterol: Less than 100 mg/dL is optimal
  • HDL cholesterol: 40 mg/dL or higher for men, 50 mg/dL or higher for women
  • Triglycerides: Less than 150 mg/dL is normal
  • VLDL cholesterol: Less than 30 mg/dL is normal

What Causes High VLDL Cholesterol?

Multiple factors can contribute to elevated VLDL levels, and understanding these causes is the first step toward managing your cardiovascular health. Since VLDL is closely tied to triglyceride levels, anything that raises triglycerides will typically increase VLDL as well.

Dietary Factors

Your diet significantly impacts VLDL production. The liver manufactures more VLDL particles when you consume:

  • Excess calories, especially from simple carbohydrates and added sugars
  • High amounts of saturated fats found in red meat and full-fat dairy products
  • Trans fats from processed foods (though these are now less common)
  • Alcohol, which stimulates triglyceride production in the liver
  • Refined carbohydrates like white bread, pastries, and sugary beverages

Lifestyle and Medical Conditions

Beyond diet, several lifestyle factors and health conditions can elevate VLDL levels:

  • Obesity, particularly excess abdominal fat
  • Physical inactivity and sedentary behavior
  • Type 2 diabetes and insulin resistance
  • Metabolic syndrome
  • Hypothyroidism
  • Chronic kidney disease
  • Certain medications, including steroids, beta-blockers, and some diuretics
  • Genetic factors, including familial hypertriglyceridemia

The relationship between insulin resistance and VLDL is particularly important. When your cells become resistant to insulin, your liver produces more VLDL particles, creating a cycle that can worsen both metabolic and cardiovascular health. Regular monitoring through comprehensive metabolic panels can help identify these issues early.

Health Risks Associated with High VLDL

Elevated VLDL cholesterol poses significant health risks, primarily related to cardiovascular disease. Like LDL particles, VLDL can penetrate arterial walls and contribute to plaque formation. This process, called atherosclerosis, narrows and hardens arteries over time.

The cardiovascular risks associated with high VLDL include:

  • Coronary artery disease, potentially leading to heart attacks
  • Cerebrovascular disease, increasing stroke risk
  • Peripheral artery disease, affecting blood flow to limbs
  • Increased risk of blood clots
  • Higher likelihood of developing metabolic syndrome

Research published in the Journal of the American College of Cardiology has shown that VLDL particles, particularly small, dense VLDL particles, are independently associated with cardiovascular disease risk. This association remains significant even after accounting for LDL cholesterol levels, highlighting the importance of addressing all components of your lipid profile.

High VLDL also contributes to a condition called diabetic dyslipidemia, characterized by high triglycerides, low HDL, and small, dense LDL particles. This lipid pattern significantly increases cardiovascular risk in people with diabetes or prediabetes.

Natural Ways to Lower VLDL Cholesterol

The good news is that VLDL levels often respond well to lifestyle modifications. Since VLDL is closely tied to triglyceride levels, strategies that lower triglycerides will typically reduce VLDL as well.

Dietary Strategies

Making strategic dietary changes can significantly impact your VLDL levels:

  • Reduce simple carbohydrates and added sugars - aim for less than 10% of daily calories from added sugars
  • Increase omega-3 fatty acids from fish like salmon, mackerel, and sardines
  • Choose complex carbohydrates with fiber, such as whole grains, legumes, and vegetables
  • Limit alcohol consumption, as even moderate drinking can raise triglycerides in sensitive individuals
  • Practice portion control to maintain a healthy weight
  • Include nuts, seeds, and olive oil for healthy fats

Exercise and Physical Activity

Regular physical activity is one of the most effective ways to lower VLDL cholesterol. Exercise helps in multiple ways:

  • Increases lipoprotein lipase activity, which breaks down triglycerides
  • Improves insulin sensitivity, reducing VLDL production
  • Helps with weight management
  • Raises HDL cholesterol, improving your overall lipid profile

Aim for at least 150 minutes of moderate-intensity aerobic exercise or 75 minutes of vigorous exercise weekly. Resistance training twice a week provides additional metabolic benefits. Even modest increases in physical activity can lead to meaningful improvements in VLDL levels.

Weight Management and Other Lifestyle Factors

Achieving and maintaining a healthy weight is crucial for VLDL management. Even a 5-10% reduction in body weight can significantly lower triglyceride and VLDL levels. Focus on sustainable weight loss through balanced nutrition and regular physical activity rather than extreme diets.

Other important lifestyle modifications include:

  • Managing stress through meditation, yoga, or other relaxation techniques
  • Getting adequate sleep (7-9 hours nightly)
  • Quitting smoking, which improves overall cardiovascular health
  • Staying hydrated and limiting sugary beverages

When to Consider Medical Treatment

While lifestyle modifications are the first-line approach for managing VLDL cholesterol, some individuals may need medication to achieve optimal levels. Your healthcare provider might recommend pharmaceutical intervention if:

  • Your triglyceride levels remain above 200 mg/dL despite lifestyle changes
  • You have established cardiovascular disease
  • You have diabetes with poor lipid control
  • You have a family history of premature heart disease
  • You have multiple cardiovascular risk factors

Common medications for managing high VLDL and triglycerides include:

  • Statins: Primarily lower LDL but also reduce VLDL production
  • Fibrates: Specifically target triglyceride reduction
  • Omega-3 fatty acid supplements: Prescription-strength formulations for very high triglycerides
  • Niacin: Though less commonly used due to side effects
  • PCSK9 inhibitors: For severe cases or statin intolerance

The decision to start medication should be made in consultation with your healthcare provider, considering your overall cardiovascular risk profile, not just isolated VLDL levels. Regular monitoring helps ensure treatment effectiveness and allows for adjustments as needed.

Taking Control of Your VLDL Levels

Managing VLDL cholesterol is an important component of cardiovascular health that often gets overlooked in favor of the more well-known LDL and HDL cholesterol. However, as we've seen, VLDL plays a crucial role in your body's lipid metabolism and directly impacts your risk for heart disease and stroke.

The encouraging news is that VLDL levels are highly responsive to lifestyle changes. By focusing on a balanced diet low in simple sugars and refined carbohydrates, maintaining regular physical activity, achieving a healthy weight, and managing stress, most people can significantly improve their VLDL levels without medication.

Remember that cardiovascular health is a long-term commitment, not a short-term fix. Small, sustainable changes often yield better results than dramatic but temporary modifications. Regular monitoring of your lipid profile helps you track progress and make informed decisions about your health. Whether through lifestyle changes alone or in combination with medical treatment, taking proactive steps to manage your VLDL cholesterol is an investment in your long-term health and vitality.

References

  1. Nordestgaard, B. G., & Varbo, A. (2014). Triglycerides and cardiovascular disease. The Lancet, 384(9943), 626-635.[PubMed][DOI]
  2. Packard, C. J., & Shepherd, J. (1997). Lipoprotein heterogeneity and apolipoprotein B metabolism. Arteriosclerosis, Thrombosis, and Vascular Biology, 17(12), 3542-3556.[PubMed]
  3. Miller, M., Stone, N. J., Ballantyne, C., et al. (2011). Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 123(20), 2292-2333.[PubMed][DOI]
  4. Ginsberg, H. N., Packard, C. J., Chapman, M. J., et al. (2021). Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies. European Heart Journal, 42(47), 4791-4806.[PubMed][DOI]
  5. Berglund, L., Brunzell, J. D., Goldberg, A. C., et al. (2012). Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 97(9), 2969-2989.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my VLDL at home?

You can test your VLDL at home with SiPhox Health's Heart & Metabolic Program or Ultimate 360 Health Program. Both CLIA-certified programs include VLDL testing as part of comprehensive lipid panels, providing lab-quality results from the comfort of your home.

What is the difference between VLDL and LDL cholesterol?

VLDL primarily carries triglycerides (50-65%) and contains only 10-15% cholesterol, while LDL carries mostly cholesterol (45%) with minimal triglycerides (10%). VLDL particles are produced by your liver and eventually transform into LDL particles as they deliver triglycerides throughout your body.

What foods should I avoid to lower VLDL cholesterol?

To lower VLDL, limit simple sugars, refined carbohydrates, alcohol, saturated fats from red meat and full-fat dairy, and trans fats from processed foods. Focus instead on whole grains, lean proteins, omega-3 rich fish, and plenty of fruits and vegetables.

Can exercise really lower VLDL cholesterol?

Yes, regular exercise is highly effective at lowering VLDL. Physical activity increases lipoprotein lipase activity which breaks down triglycerides, improves insulin sensitivity to reduce VLDL production, and helps with weight management. Aim for at least 150 minutes of moderate exercise weekly.

When should I be concerned about my VLDL levels?

VLDL levels above 30 mg/dL are considered high. You should be particularly concerned if you have additional risk factors like diabetes, obesity, family history of heart disease, or if your triglycerides are above 200 mg/dL despite lifestyle changes. Consult your healthcare provider for personalized guidance.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details